Global Pharma R&D has reached an unprecedented level in extending patients’ life and improving their quality of life, driven by breakthrough innovations
This new position paper:
- Assesses the global pharma R&D trends
- Provides an overview of 2030 key therapeutic areas and products
- Analyzes the top 20 pharma R&D spenders and their pipelines
- Highlights key strategic and operational drivers to enhance pharma R&D efficiency:
